Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.73 USD
Change Today +0.19 / 3.43%
Volume 7.4M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - exelixis inc (EXEL)

Name (Connections)Board RelationshipsTitleKey Developments
Charles Cohen Ph.D. 36 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Jack Wyszomierski 45 RelationshipsDirector and Chairman of Audit Committee 

Compensation Committee* - exelixis inc (EXEL)

Name (Connections)Board RelationshipsTitle
Charles Cohen Ph.D. 36 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Vincent Marchesi M.D., Ph.D. 20 RelationshipsDirector, Member of Research & Development Committee and Member of Compensation Committee
Lance Willsey M.D. 12 RelationshipsDirector, Member of Compensation Committee and Member of Research & Development Committee
EXEL Compensation vs. Industry
755.2K
359.9K
Chief Executive Officer
Share price activity for EXELIXIS INC (EXEL)
52 Week Price Performance
EXEL
Industry Average

Nominating Committee* - exelixis inc (EXEL)

Name (Connections)Board RelationshipsTitleKey Developments
George Poste D.V.M., Ph.D., F.R.C.Path, F.R.S. 112 RelationshipsDirector, Chairman of Research & Development Committee and Member of Nominating & Corporate Governance CommitteeExelixis, Inc. Announces Executive Changes
07/16/15
Alan Garber M.D., Ph.D. 53 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeExelixis, Inc. Promotes Deborah Burke to Senior Vice President and Chief Financial Officer
09/25/14
Carl Feldbaum Esq. 64 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeExelixis, Inc. Announces Management Changes, Effective from June 2, 2014
05/8/14

Corporate Governance Committee* - exelixis inc (EXEL)

Name (Connections)Board RelationshipsTitle
Carl Feldbaum Esq. 64 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Alan Garber M.D., Ph.D. 53 RelationshipsDirector, Member of Research & Development Committee and Member of Compensation Committee
George Poste D.V.M., Ph.D., F.R.C.Path, F.R.S. 112 RelationshipsDirector, Member of Compensation Committee and Member of Research & Development Committee
EXEL and Competitor
Insiders vs. External
Board
15%
85%
Exelixis, Inc.
10%
90%
Ariad Pharmaceuticals Inc.
9%
91%
Array BioPharma Inc.
15%
85%
CTI BioPharma Corp.
22%
78%
Curis, Inc.
0%
100%
Evotec AG
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $5.73 USD +0.19

EXEL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $8.16 USD +0.31
Array BioPharma Inc $5.81 USD +0.06
CTI BioPharma Corp $1.85 USD +0.005
Curis Inc $3.14 USD -0.06
Evotec AG €3.38 EUR -0.029
View Industry Companies
 

Industry Analysis

EXEL

Industry Average

Valuation EXEL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 37.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 26.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.